Etao International Co., Ltd. · OTC:ETAOF

Etao International — SPAC Merger (January 2022)

23 slides from Etao International's SPAC merger presentation, Jan 31, 2022

  1. Slide 1: ETAO International Group: A Patient-Centric Medical Ecosystem Powered by Digital Technology

    ETAO International Group A Patient - Centric Medical Ecosystem Powered by Digital Technology Confidential and Proprietary Information A leading digital healthcare group providing transformative medical care and quality service January 2022

  2. Slide 2: Important Notices and Disclaimers

    Important Notices and Disclaimers Disclaimer This presentation (the “Presentation”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination (the “Business Combination”) between Mountain Crest Acquisition Corp .

  3. Slide 3: Important Notices and Disclaimers: Forward-Looking Statements

    Important Notices and Disclaimers Forward - Looking Statements . Certain statements in this Presentation may be considered forward - looking statements . Forward - looking statements generally relate to future events or Mountain Crest’s or the Company’s future financial or operating performance . Fo

  4. Slide 4: Important Notices and Disclaimers: Additional Information

    Important Notices and Disclaimers Additional Information . In connection with the proposed Business Combination, Mountain Crest or one of its subsidiaries intends to file with the SEC a registration statement on Form F - 4 or S - 4 containing a preliminary proxy statement/prospectus of Mountain Cres

  5. Slide 5: Important Notices and Disclaimers: Risk Factors

    Important Notices and Disclaimers • ETAO International Group is a federating healthcare agency, patient - centric case management company, aiming to provide integrate d community healthcare network. • Risk Factors The list below of risk factors has been prepared as part of the Business Combination.

  6. Slide 6: Important Notices and Disclaimers: Risk Factors (cont.)

    Important Notices and Disclaimers Risk Factors Related to business and industry (cont….) • Sales agents and employee misconduct is difficult to detect and deter and could harm ETAO’s reputation or lead to regulatory san ctions or litigation costs. • ETAO’s success depends upon market acceptance of i

  7. Slide 7: Proposed Business Combination Transaction

    7 PROPOSED BUSINESS COMBINATION TRANSACTION T RANSACTION O VERVIEW • ETAO International Group (“ETAO”) and Mountain Crest Acquisition Corp. III (“Mountain Crest”) expect to execute definitive agreement for a business combination (the “Transaction”) before January 28, 2022. • The Transaction is expec

  8. Slide 8: Today's Presenters - Executive Management Team

    Today’s Presenters - Executive Management Team Founder, Chairman, CEO Wilson Liu MS Chairman, Founder, CEO of ETAO International Group • 25+ years in Wall Street • Founder of WSHP Capital • President of Wall Street Huangpu Center • Former CFO for Apollo Solar (ASOE) • Managing Director of American E

  9. Slide 9: Introduction - ETAO Is a Strategic Fit for Healthcare-focused Investors

    Introduction - ETAO Is a Strategic Fit for Healthcare - focused Investors Patient - Centric Healthcare Guiding Principle Compelling Market Drivers Innovative and Adaptive Ecosystem Provided by 12 Variable Interest Entities (VIEs) Unique Investment Proposition Visionary Leadership Team ETAO plans to

  10. Slide 10: ETAO's Healthcare Business Model Provided by Variable Interest Entities

    Introducing ETAO’s Healthcare Business Model Provided by 12 Variable Interest Entities (“VIEs”) (3) Provided by ETAO’s 12 VIEs Tele - Medicine Online Insurance / Pharma AI/Big Data Diagnosis Offline Hospitals / Clinics Biotech • ETAO is currently integrating a comprehensive medical ecosystem that wi

  11. Slide 11: A Closer Look at ETAO's Healthcare Ecosystem Provided by VIEs

    A Closer Look at ETAO’s Healthcare Ecosystem Provided by 12 VIEs (7) DIGITAL ASSETS (6 VIE Entities) Dnurse • One of China’s leading diabetes platforms • 1.6 million users • Device + app + health mgt system • Data - based, digital, personalized intervention plan • Based in Beijing Beijing Chainworks

  12. Slide 12: A Closer Look at ETAO's Healthcare Ecosystem (cont'd)

    A Closer Look at ETAO’s Healthcare Ecosystem Provided by 12 VIEs (cont’d) (8) OFFLINE ASSETS (6 VIE Entities) Mengzhou Hospital • Level 2 hospital • 30+ clinical medical and technical departments • Orthopedic and general surgery, neurosurgery, neurology, urology, ob/gyn, etc. • Based in Henan Changx

  13. Slide 13: Closer Look at ETAO's Dnurse - Digital Diabetes Management Solution

    Closer Look At ETAO’s Dnurse – Digital Diabetes Management Solution (9) (9) This chart provides a description of one of our VIEs (Dnurse). 13

  14. Slide 14: Projected Expansion of ETAO's Current VIE Digital Assets

    Projected Expansion of ETAO’s Current Variable Interest Entity (VIE) Digital Assets (10) 2022 2023 2024 2025 2026 2022 • 8.4 million telemedicine users • 166 “internet” hospitals • 370 rural clinics; 470 senior care facilities • 3 mm online insurance clients 2023 • 10 mm users • 226 “internet” hospi

  15. Slide 15: Five Year Projected Revenue and Operating Income

    Five Year Projected Revenue and Operating Income of ETAO’s 12 Current VIE Operating Entities (11 ) and Potential Future Acquisitions 2022 ETAO ESTIMATED REVENUE (USD) $133 mm 2023 2024 $199 mm $299 mm $425 mm $637 mm 2025 2026 ETAO ESTIMATED OPERATING INCOME (USD) 2022 $5 mm 2023 2024 $15 mm $34 mm

  16. Slide 16: ETAO's Comprehensive Ecosystem Compared to Global Peers

    ETAO’s Comprehensive Ecosystem (12 VIEs) Compared to Global Peers COMPETITOR ANALYSIS – ETAO’S COMPREHENSIVE ECOSYSTEM ETAO INT’L GROUP WATERDROP (12) PING’AN GOOD DOCTOR (13) YIDU CLOUD (14) TELE - DOC (15) LINKDOC (16) CAPABILITY Targeting NYSE Nasdaq Listed Hong Kong Listed HK Listed NYSE Listed

  17. Slide 17: ETAO Has Implemented Key Governance Elements

    ETAO Has Implemented Key Governance Elements Financials for 2020 and 2021 in progress by a PCAOB - certified auditor Legal entity structure subjected to external legal review and opinion Strong, multi - layered corporate governance program at group, China and operating entity levels Robust internal

  18. Slide 18: Appendix

    APPENDIX • List of Government Policies for Supporting China’s Healthcare Development • Executive Management Team (Full Bios) • Board of Directors Bios 18

  19. Slide 19: China Government Policies That Support Healthcare Development

    China Government Policies That Support Healthcare Development February, 2020 March, 2020 National Health Commission ➢ “Notice on Strengthening Information Technology to Support the Prevention and Control of Pneumonia Infected by Novel Coronavirus ” http://www.nhc.gov.cn/xcs/zhengcwj/202002/5ea1b9fca

  20. Slide 20: Experienced Management Team

    Experienced Management Team Founder, CEO Wilson Liu MS Chairman, Founder, CEO of ETAO International Group Founder of WSHP Capital; President of Wall Street Huangpu Center; Former CFO for Apollo Solar (ASOE); Managing Director of American Education Center; Co - founder of Beijing CSII Software Co. LT

  21. Slide 21: Experienced Management Team (cont'd)

    Experienced Management Team (cont’d) CFO Joel A. Gallo MPA, MA Chief Financial Officer of ETAO International Group (Shanghai - based) 25+ years in global banking/finance, tech; Member of the Board of Directors of Hywin Wealth Management - Chinese firm and NASDAQ listed (Ticker - HYW); Adjunct Facult

  22. Slide 22: Seasoned Board of Directors

    Seasoned Board of Directors Independent Director, Head of Nomination Committee Kenneth Liang MBA - Over 40 years of international insurance experience - Leader with international / industry expertise and functional know - how, a thinker with ability to analyze the industry landscape and a visionary

  23. Slide 23: Seasoned Board of Directors (cont'd)

    Seasoned Board of Directors (cont’d) Independent Director, Head of Audit Committee Philip Moody MBA - Former Executive Vice President and CFO of PaxVax, an international firm novel vaccines - Instrumental in the sale of PaxVax to Emergent BioSolutions - Chief financial officer of BTG Ltd. North Amer

ETAO International Group — SPAC Merger (January 2022) on 6ix